WellDyne Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care

Scipher Medicine Brings Precision Medicine Platform to Patient-Centered MIT Initiative

New Study Demonstrates Clinical Utility of PrismRA Test in Guiding Therapy Selection for Rheumatoid Arthritis Patients

Mariann Byerwalter joins Scipher Medicine’s Board of Advisors

18th U.S. Surgeon General Joins Scipher Medicine

Scipher Medicine and Ambry Genetics Partner to Bring Precision Medicine Test for Rheumatoid Arthritis to Market

New Strategy for Avoiding Waste and Improving Response for Highest Cost Therapies in Rheumatoid Arthritis

Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease

Scipher Medicine Announces Publication of Clinical Study Validating PrismRA, a Blood Test Predicting Non-Response to TNF Inhibitor Therapies in Patients with Rheumatoid Arthritis

Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis Patients

Scipher Medicine Welcomes Jerry Conway, Appointed Senior Vice President of Market Access

Pandemic versus pandemonium: fighting on two fronts